Publication summary

Showing 9 of 0 results

• Incidence of neutropenia adverse events identified in electronic health care records among initiators of CDK4/6 inhibitors with advanced breast cancer in the UK

  ISPOR Europe

  • Publication summary
  • Publications
  • Breast cancer
• Assessing bias in LLM-extracted real-world data: A health equity analysis of access to care and outcomes in metastatic breast cancer

  ISPOR Europe

  • Publication summary
  • Publications
  • Metastatic breast cancer
• Real-world insights into prostate cancer management using EHR-derived data from the UK

  ISPOR Europe

  • Publication summary
  • Publications
  • Prostate cancer
• Transportability of overall survival in multiple myeloma from the US to Germany: A benchmarking study

  ISPOR Europe

  • Publication summary
  • Publications
  • Multiple myeloma
• Real-world study of breast cancer epidemiology and treatment patterns: A pilot study to assess EHR-derived data in the United Kingdom

  ISPOR Europe

  • Publication summary
  • Publications
  • Breast cancer
• Fit-for-purpose real-world data: Lessons from FDA QCARD and EMA Data Quality Framework

  ISPOR Europe

  • Publication summary
  • Publications
  • Regulatory
• Descriptive comparison of patient characteristics and treatment patterns in metastatic NSCLC: US and France cohorts to inform transportability

  ISPOR Europe

  • Publication summary
  • Publications
  • Non-small cell lung cancer
• Laboratory testing patterns in patients with breast cancer treated With CDK4/6 Inhibitors: A multi-country electronic health record study from the UK, Germany, and Japan

  ISPOR Europe

  • Publication summary
  • Publications
  • Breast cancer
• Advancing real-world evidence in diffuse large B-Cell lymphoma: Insights from EHR-derived data in the UK

  ISPOR Europe

  • Publication summary
  • Publications
  • Diffuse large B-Cell lymphoma